TXNIP and alkaline phosphatase measurement: Our experimental results also confirmed that Drug D, which acted as a GSDMD antagonist, efficiently decreased ERS by decreasing the accumulation of GSDMD in the ER through the TXNIP/HIF-1α pathway in AP.